Select Document
✔
{hosting_shortdoctitlestripped}
✔
{doc1_shortdoctitlestripped}
✔
{doc2_shortdoctitlestripped}
✔
{doc3_shortdoctitlestripped}
✔
{doc4_shortdoctitlestripped}
✔
{doc5_shortdoctitlestripped}
✔
{doc6_shortdoctitlestripped}
✔
{doc7_shortdoctitlestripped}
✔
{doc8_shortdoctitlestripped}
✔
{doc9_shortdoctitlestripped}
✔
{doc10_shortdoctitlestripped}
✔
{doc11_shortdoctitlestripped}
✔
{doc12_shortdoctitlestripped}
✔
{doc13_shortdoctitlestripped}
✔
{doc14_shortdoctitlestripped}
✔
{doc15_shortdoctitlestripped}
Notice of 2018 Annual Meeting and Proxy Statement
Pfizer at a Glance
Letter from the Chairman and CEO
A Message from Pfizer's Lead Independent Director
Notice of 2018 Annual Meeting and Proxy Statement
Table of Contents
Proxy Statement Summary
Item 1 - Election of Directors
Criteria for Board Membership
Selection of Candidates
Retirement Policy
Our 2018 Director Nominees
Director Nominees
Governance
Overview
Board Information
Board Leadership Structure
The Board's Role in Risk Oversight
The Board's Oversight of Company Strategy
The Board's Role in Succession Planning
Evaluating Board Effectiveness
Board and Committee Information
Corporate Governance Committee Report
Regulatory and Compliance Committee Report
Shareholder Outreach
Corporate Responsibility and Sustainability
Public Policy Engagement and Political Participation
Pfizer Policies on Business Conduct
Other Governance Practices and Policies
Non-Employee Director Compensation, Ownership & Related Person Transactions
Non-Employee Director Compensation
2017 Director Compensation Table
Securities Ownership
Beneficial Owners
Section 16(a) Beneficial Ownership Reporting Compliance
Related Person Transactions and Indemnification
Item 2 - Ratification of Selection of Independent Registered Public Accounting Firm
Audit and Non-Audit Fees
Audit Committee Report
Item 3 - 2018 Advisory Approval of Executive Compensation
Results of 2017 Advisory Vote on Executive Compensation
2017 Pay for Performance
2018 Advisory Vote on Executive Compensation
Item 4 - Approval of the Pfizer Inc. French Sub-Plan under the 2014 Stock Plan
Compensation Committee Report
Executive Compensation
Compensation Discussion and Analysis
Table of Contents
Executive Summary
Compensation Tables
Financial Measures
Shareholder Proposals
Item 5 - Right to Act by Written Consent
Item 6 - Independent Chair Policy
Item 7 - Report on Lobbying Activities
Other Information
Annual Meeting Information
Annual Meeting
Voting
Proxy Materials
Other Questions
Other Business
Submitting Proxy Proposals and Director Nominations for the 2019 Annual Meeting
Annex 1 - Corporate Governance Principles
Annex 2 - Pfizer Inc. 2014 Stock Plan - French-Qualified Restricted Stock Unit Sub-Plan
Corporate and Shareholder Information
Working for a Sustainable Future
Meet our Director Nominees
Help & Features
Download PDF
Downloads
Company Home
Share
Print
Clickable Index
Thumbnails
Accessibility Features
Help
Zoom Out
Home
Home
PDF
PDF
PDF
Help
Help
Unpin Menu Bar
Pin Menu Bar
Go to previous page
Go to previous page
Go to previous page
Go to previous page
Go to next page
Go to next page
Go to next page
Page 17 of 129
Single Page View
Double Page View
...Previous
Continue...
WARNING: JavaScript is disabled.
CLICK HERE
for help.
Click here
for a list of supported browsers.
